0001882653-22-000001.txt : 20220928 0001882653-22-000001.hdr.sgml : 20220928 20220928145123 ACCESSION NUMBER: 0001882653-22-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20220928 DATE AS OF CHANGE: 20220928 EFFECTIVENESS DATE: 20220928 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JPAS - Illiquid Assets LLC - Life Sciences 2022 Series CENTRAL INDEX KEY: 0001882653 IRS NUMBER: 870860779 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-414397 FILM NUMBER: 221275117 BUSINESS ADDRESS: STREET 1: 100 PINE STREET, SUITE 2600 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 BUSINESS PHONE: 415-417-3000 MAIL ADDRESS: STREET 1: 100 PINE STREET, SUITE 2600 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 D/A 1 primary_doc.xml X0708 D/A LIVE 0001882653 JPAS - Illiquid Assets LLC - Life Sciences 2022 Series 100 Pine Street, Suite 2600 San Francisco CA CALIFORNIA 94111 415-417-3000 DELAWARE None None Limited Liability Company true 2021 n/a Jordan Park Group LLC 100 Pine Street, Suite 2600 San Francisco CA CALIFORNIA 94111 Promoter Manager of the Issuer Frank S. Ghali 100 Pine Street, Suite 2600 San Francisco CA CALIFORNIA 94111 Executive Officer George H. Lusch 100 Pine Street, Suite 2600 San Francisco CA CALIFORNIA 94111 Executive Officer Davie M. Baccei 1 World Trade Center, Suite 71A New York NY NEW YORK 10007 Executive Officer David S. Lee 100 Pine Street, Suite 2600 San Francisco CA CALIFORNIA 94111 Executive Officer Heather H. Brownlie 100 Pine Street, Suite 2600 San Francisco CA CALIFORNIA 94111 Executive Officer Samantha R. Brown 100 Pine Street, Suite 2600 San Francisco CA CALIFORNIA 94111 Executive Officer Pooled Investment Fund Private Equity Fund false Decline to Disclose 06b 3C 3C.7 true 0001501011-22-000005 2021-09-15 true true false 10000 Indefinite 31175000 Indefinite false 30 0 0 0 false JPAS - Illiquid Assets LLC - Life Sciences 2022 Series Davie M. Baccei Davie M. Baccei SVP and Chief Compliance Officer of the Issuer's Manager 2022-09-28